latrepirdine has been researched along with Amyotrophic Lateral Sclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hawker, DD; Jansen Labby, K; Mataka, JJ; Silverman, RB; Trippier, PC | 1 |
| Bachurin, SO; Buchman, VL; Chaprov, K; Deykin, AV; Funikov, S; Ivanova, TA; Kukharsky, MS; Lysikova, EA; Ninkina, N; Rezvykh, A; Yu Aksinenko, A | 1 |
| Coughlan, KS; Hogg, MC; Mitchem, MR; Prehn, JH | 1 |
| Akiyama, H; Arai, T; Bachurin, SO; Buchman, VL; Goedert, M; Hasegawa, M; Kametani, F; Ninkina, N; Nonaka, T; Yamashita, M | 1 |
| Afanasieva, MA; Alentov, II; Bachurin, SO; Buchman, VL; Khritankova, I; Ninkina, NN; Peters, O; Shelkovnikova, TA; Tarasova, TV; Ustyugov, AA | 1 |
| Burket, A; Drawbridge, J; Estill, SJ; Huntington, P; Knobbe, W; McDaniel, L; McKnight, SL; Morlock, L; Naidoo, J; Pieper, AA; Ready, JM; Starwalt, R; Tesla, R; Tran, S; Williams, NS; Wolf, HP; Xu, P | 1 |
1 review(s) available for latrepirdine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Calcium Channels; Drug Combinations; Drug Design; Humans; Huntington Disease; Neurodegenerative Diseases; Nitric Oxide Synthase Type I; Oxidative Stress; Parkinson Disease; Protein Folding; Protein Structure, Quaternary; Proteostasis Deficiencies; Receptors, N-Methyl-D-Aspartate | 2013 |
5 other study(ies) available for latrepirdine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Gait; Humans; Indoles; Mice; Mice, Transgenic; RNA-Binding Protein FUS | 2021 |
"Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
Topics: AMP-Activated Protein Kinases; Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Cells, Cultured; Disease Progression; Energy Metabolism; Enzyme Activation; Female; Indoles; Injections, Intraperitoneal; Male; Mice, Inbred C57BL; Mice, Transgenic; Motor Neurons; Mutation; Risk; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1 | 2015 |
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Cell Line; Dementia; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Inclusion Bodies; Indoles; Methylene Blue | 2009 |
Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice.
Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; gamma-Synuclein; Indoles; Male; Mice; Mice, Transgenic; Motor Neurons; Neuroprotective Agents; Rotarod Performance Test; Spinal Cord | 2012 |
Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Carbazoles; Indoles; Mice; Motor Activity; Motor Neurons; Neuroprotective Agents; Polymerase Chain Reaction; Rotarod Performance Test; Spinal Cord | 2012 |